Corteva has received 6 bullish analyst ratings in the last quarter, indicating a positive outlook for the stock. The average 12-month price target of $74.17, although down 3.05% from the previous average, still suggests potential upside for the stock. This information is relevant and important for investors as it reflects the analysts' positive sentiment towards the company, which could lead to a short-term increase in the stock price.